Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 2,793,000 | 2,535,500 | 2,496,700 | 1,979,244 | 1,646,203 |
| Cost of Goods | 1,596,800 | 1,502,800 | 1,504,800 | 1,233,483 | 852,414 |
| Gross Profit | 1,196,200 | 1,032,700 | 991,900 | 745,761 | 793,789 |
| Operating Expenses | 813,100 | 675,300 | 737,000 | 1,168,340 | 575,691 |
| Operating Income | 383,900 | 358,200 | 255,700 | -422,096 | 218,512 |
| Interest Expense | 34,200 | 28,200 | 44,500 | 22,082 | 14,524 |
| Other Income | 12,900 | 28,300 | 13,000 | 33,229 | 15,946 |
| Pre-tax Income | 362,600 | 358,300 | 224,200 | -410,949 | 219,934 |
| Income Tax | 140,600 | 119,900 | 83,200 | 34,056 | 81,377 |
| Net Income Continuous | 222,000 | 238,400 | 141,000 | -445,005 | 138,557 |
| Net Income | $222,000 | $238,400 | $141,000 | $-445,005 | $138,557 |
| EPS Basic Total Ops | 2.11 | 2.32 | 1.38 | -4.37 | 1.32 |
| EPS Basic Continuous Ops | 2.11 | 2.32 | 1.38 | -4.37 | 1.32 |
| EPS Diluted Total Ops | 1.96 | 2.09 | 1.27 | -4.37 | 1.22 |
| EPS Diluted Continuous Ops | 1.91 | 2.03 | 1.21 | -4.37 | 1.15 |
| EBITDA(a) | $572,900 | $528,900 | $509,300 | $-203,750 | $425,238 |